| NCT07153146 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects. | NOT_YET_RECRUITING | PHASE1 | 2025-09-08 | 2026-06-15 | 2026-06-15 |
| NCT06033586 | Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-01-22 | 2027-04-01 | 2026-04-01 |
| NCT05210790 | A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-04-01 | 2027-06 | 2025-02-21 |
| NCT04819620 | Pharmacokinetics of PN-232 in Healthy Volunteers | COMPLETED | PHASE1 | 2021-05-13 | 2022-06-16 | 2021-12-17 |
| NCT04767802 | PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit | COMPLETED | PHASE2 | 2021-02-02 | 2023-03-15 | 2023-03-15 |
| NCT04621630 | Pharmacokinetics of PN-235 in Healthy Volunteers | COMPLETED | PHASE1 | 2020-11-12 | 2021-10-13 | 2021-09-19 |
| NCT04516382 | Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers | COMPLETED | PHASE1 | 2020-09-14 | 2021-06-30 | 2021-01-12 |
| NCT04504383 | PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC) | COMPLETED | PHASE2 | 2020-08-05 | 2023-02-16 | 2023-02-16 |
| NCT04202965 | PTG-300 in Subjects With Hereditary Hemochromatosis | COMPLETED | PHASE2 | 2020-03-19 | 2022-02-15 | 2021-10-06 |
| NCT04057040 | Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE) | COMPLETED | PHASE2 | 2019-10-01 | 2024-06-17 | 2023-02-14 |
| NCT04054921 | Safety Study for Beta Thalassemia Subjects on PTG-300 | COMPLETED | PHASE2 | 2019-05-10 | 2020-07-31 | 2020-07-31 |
| NCT03802201 | Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia | COMPLETED | PHASE2 | 2018-12-19 | 2020-07-31 | 2020-07-31 |
| NCT02895100 | Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis | TERMINATED | PHASE2 | 2016-12 | 2018-03-26 | 2018-03-26 |